Hints and tips:
Related Special Reports
...Health authorities had also hoped it could help sway sceptics who preferred not to receive an mRNA vaccine, though demand has since collapsed....
...Humana, with significant exposure to Medicare Advantage, was the biggest loser in the S&P 500. Its 13.4 per cent drop on Tuesday represented its third-biggest one-day fall of the past decade....
...US health insurer Cigna has abandoned plans to merge with Humana, a blockbuster transaction that would have created a $140bn insurance giant, according to people familiar with the matter....
...A combination between Cigna and Humana would help the companies compete with larger rivals such as UnitedHealth Group and Elevance Health, formerly known as Anthem....
...Humana, which has significant exposure to Medicare Advantage plans, was the biggest loser in the S&P 500....
...US health insurer Cigna has abandoned plans to merge with Humana, a blockbuster transaction that would have created a $140bn insurance company, according to people familiar with the matter....
...Insurers have targeted enrolment in Medicare Advantage plans, private versions of the US health program for seniors. This is the industry’s biggest growth engine....
...Cigna jumped 16 per cent after the US health insurer abandoned plans to merge with Humana and said it will increase stock repurchases by $10bn. Humana fell 1.3 per cent....
...It has abandoned plans for two treatments already. It is working on developing a once-a-day version of its own obesity pill danuglipron after dropping plans for a twice-daily pill....
...One thing to start: Cigna is in talks to merge with Humana in a deal that would create a US health insurance giant worth $140bn and provide a significant test for antitrust authorities, according to people...
...Menopause has risen up employers’ agenda as acceptance grows that once-private issues, such as mental health, have an impact on working life....
...Hang it on Hunt’s announcement of an NHS productivity plan. I want to turn their thoughts into a pamphlet. A manifesto for AI in the NHS; or maybe it’s the AINHS; the NAIHS?...
...Pfizer is abandoning its plans for a weight loss pill to be taken twice a day after trials showed it caused significant side effects, in a setback to the US drugmaker’s effort to enter the fast-growing market...
...NHS England said the software would enable staff to “plan and maximise resources such as operating theatre and outpatient clinic time to ensure patients receive more timely care”....
...To make up for the shortfall in its pipeline, the US drugmaker earlier this year announced plans to buy Seagen, an oncology drugmaker, for $43bn; a deal Pfizer said it expected to close on Thursday....
...Cigna, the US health insurer, has pulled out of plans to merge with Humana in what would have marked the largest deal of the year....
...The US group plans to cut about $1bn in costs this year....
...For many farmers, regenerative agriculture is more to do with the health of their land than of their bank balances....
...Roche plans to buy immunology company Telavant from Roivant Sciences and Pfizer for more than $7bn, as the drugmaker’s new chief executive seeks to replenish its drug pipeline....
...He said chancellor Jeremy Hunt and the health department should address conflicts with the pharmaceutical industry over drug prices and hurdles to running clinical trials in the NHS....
...Still keen Panasonic Energy still plans to build a third electric vehicle battery plant in the US despite scrapping a tentative plan last year to construct a facility in Oklahoma, writes Nikkei Asia’s Ryohtaroh...
...So he submitted an official complaint to the county health department....
...But early indications of MA enrolment for 2024 have not been great, and if that plays out, Cigna’s greater exposure to commercial health plans may turn into a relative advantage....
...While some investors are sceptical of companies without long-term growth plans, she said Moderna had met every challenge....
International Edition